The U.S. Food and Drug Administration has approved Datroway (datopotamab deruxtecan-dlnk) for adult patients with ...
As seen in the DESTINY-Breast06 trial, approximately 20-25 percent of hormone receptor (HR)-positive, HER2-negative breast ...
One of the most important launches for Novartis in recent years is off with a bang. | One of the most important launches for ...
A recent study published in JAMA explored whether getting telehealth visits, rather than in-person visits, affects the ...
The decline in cancer incidence among men and increase among women has narrowed the male‐to-female cancer incidence rate ratio from a peak of 1.6 in 1992 to 1.1 in 2021. In people aged 50-64 years, ...
A far shorter, simpler, and less toxic treatment protocol for patients with triple-negative breast cancer produced outcomes ...
The European Medicines Agency (EMA) has approved the expansion of Greenwich LifeSciences’ Phase III FLAMINGO-01 breast cancer ...
Enhertu first secured approval in 2019 for patients with high levels of HER2, a protein that promotes cancer cell growth. In ...
Can pollution cause it? What about inflammation? And how do tumors spread? Here’s what scientists are learning about this ...
In a candid Instagram post, the star shared the unexpected news of her 8th surgery and the possibility of a 9th.
On Tuesday, the 42-year-old entrepreneur shared a health update with her 261K Instagram followers and revealed she had to go ...
Nadine Menendez’s husband, Bob, was convicted in July 2024 of taking bribes and acting as a foreign agent while in the U.S. Senate.